Craig Hendrix, MD, on PrEP Medications to Watch Out For

In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also spoke about at IDWeek 2019.

Craig W. Hendrix, MD, is the Wellcome Professor and director of the Division of Clinical Pharmacology at Johns Hopkins University School of Medicine in Baltimore, Maryland. He is also a professor of medicine in the department of Pharmacology and Molecular Sciences in the Division of Infectious Diseases at the Bloomberg School of Public Health at Johns Hopkins.

Additional Resources:

• Hendrix CW. Prevention strategies on the horizon. Talk presented at: IDWeek 2019; October 2-6, 2019; Washington, DC. https://www.eventscribe.com/uploads/eventScribe/PDFs/2019/6886/891801.pdf.